# Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment

> **NCT02364336** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 14 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Peginterferon alfa-2a

## Key facts

- **NCT ID:** NCT02364336
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-14
- **Primary completion:** 2018-05-21
- **Final completion:** 2018-05-21
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02364336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02364336, "Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02364336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*